China Animal Husbandry Industry (600195.SH) has obtained a new animal medicine registration certificate.

China Animal Husbandry Industry (600195.SH) announced recently that, according to the Regulations on Veterinary Drugs Management and the Measures for Veterinary Drug Registration, the three-component inactivated vaccine for feline rhinotracheitis, feline calicivirus disease, and feline panleukopenia (HBJ06 strain + CHZ05 strain + PSY01 strain) declared by the company has been approved as a new veterinary drug after review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, and a new veterinary drug registration certificate has been issued. Feline panleukopenia, feline calicivirus disease, and feline rhinotracheitis are three common highly contagious diseases in cats that pose serious health risks. The three-component inactivated vaccine for feline rhinotracheitis, feline calicivirus disease, and feline panleukopenia (HBJ06 strain + CHZ05 strain + PSY01 strain) is a product independently developed by the company. The vaccine strains used are the main circulating strains in the country, and they provide good immune protection against the aforementioned cat diseases. The advanced production processes, such as full suspended culture and concentrated purification, ensure the safety, efficacy, and stability of the product. This vaccine is an important research and development achievement made by the company by focusing on its core responsibilities, emphasizing R&D efforts, and vigorously developing the pet business segment, enriching the company's product portfolio in the pet business segment. Obtaining the new veterinary drug registration certificate this time will have a positive impact on enhancing the company's competitiveness in the pet market and will be of great social and economic significance in serving and promoting the sustainable and healthy development of the pet industry.